Bio-Rad Laboratories Class B
BIO.B
7 hedge funds and large institutions have $2.88M invested in Bio-Rad Laboratories Class B in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 6 closing their positions.
2.05% less ownership
Funds ownership: 2.15% → 0.1% (-2%)
42% less funds holding
Funds holding: 12 → 7 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
97% less capital invested
Capital invested by funds: $82.4M → $2.88M (-$79.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LW
Libra Wealth
Los Gatos,
California
|
+$312K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tikvah Management
Charlotte,
North Carolina
|
-$73.3M |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$3.69M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$374K |
| 4 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
-$234K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$226K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $1.18M | -$125K | -200 | -9% |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $814K | -$3.69M | -5,930 | -80% |
|
3
Morgan Stanley
New York
| $389K | – | – | – |
|
|
LW
4
Libra Wealth
Los Gatos,
California
| $282K | +$312K | +500 | New |
|
|
GAM
5
Gemmer Asset Management
Walnut Creek,
California
| $156K | – | – | – |
|
6
Wells Fargo
San Francisco,
California
| $33K | – | – | – |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $29K | – | – | – |
|
|
TM
8
Tikvah Management
Charlotte,
North Carolina
| – | -$73.3M | -97,027 | Closed |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$374K | -496 | Closed |
|
|
GI
10
GAMCO Investors
Greenwich,
Connecticut
| – | -$234K | -310 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$226K | -299 | Closed |
|
|
OPCM
12
Osborne Partners Capital Management
San Francisco,
California
| – | -$214K | -284 | Closed |
|
13
Bank of America
Charlotte,
North Carolina
| – | -$29K | -38 | Closed |
|
BIO.B Hedge Fund Activity: Q1 2022 in Review
7 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2022, worth a combined $2.88M — down 97% from $82.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BIO.B and 1 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Libra Wealth, opening a new position worth an estimated $312K. The largest seller was Tikvah Management, exiting entirely with an estimated $73.3M sold.
- 7 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2022, down from 12 in Q4 2021.
- Funds reported $2.88M of Bio-Rad Laboratories Class B stock for Q1 2022, down 97% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q1 2022 and 6 closed out, a net change of -5 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q1 2022 was Libra Wealth, an estimated $312K added.
- The largest Bio-Rad Laboratories Class B seller in Q1 2022 was Tikvah Management, an estimated $73.3M sold.
Based on aggregated 13F filings for Q1 2022.